Clinically Relevant Concentrations of Olprinone Reverse Attenuating Effect of Propofol on Isoproterenol-induced Cyclic Adenosine Monophosphate Accumulation in Cardiomyocytes

アクセス数 : 1434
ダウンロード数 : 149

今月のアクセス数 : 0
今月のダウンロード数 : 0
ファイル情報(添付)
HiroshimaJMedSci_57_1.pdf 1.3 MB 種類 : 全文
タイトル ( eng )
Clinically Relevant Concentrations of Olprinone Reverse Attenuating Effect of Propofol on Isoproterenol-induced Cyclic Adenosine Monophosphate Accumulation in Cardiomyocytes
作成者
Kurokawa Hiromi
Matsunaga Aki
Yuge Osafumi
収録物名
Hiroshima Journal of Medical Sciences
57
1
開始ページ 1
終了ページ 6
収録物識別子
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
抄録
Propofol has been shown to attenuate β-adrenoreceptor-mediated signal transduction in cardiomyocytes. Cyclic adenosine monophosphate (cAMP) is an essential second messenger of β-signal transduction, while olprinone, a phosphodiesterase-III inhibitor, improves poor cardiac performance by increasing cAMP levels. In the present study, we investigated the effects of olprinone toward the reducing effect of propofol on β-adrenoreceptor-mediated increases in cAMP production. First, suspensions of rat ventricular myocytes were incubated with isoproterenol or olprinone and the effects on cAMP concentrations were assessed. Next, propofol was added prior to the addition of isoproterenol or olprinone. Finally, following preincubation with propofol, isoproterenol with or without olprinone was added. Both isoproterenol and olprinone increased cAMP production in a dose-dependent manner. However, clinically relevant concentrations of olprinone (up to 10-7 M) did not cause a significant increase. Propofol (l0-7-10-4 M) attenuated isoproterenol-stimulated increases in cAMP production (decrease of 2 ± 4% - 43 ± 1%, as compared to the isoproterenol-stimulated state). However, the agent did not alter olprinone (10- 7 M)-stimulated cAMP production. Olprinone (10- 8 -10-6 M) reversed the attenuating effect of propofol (l0-5 M) toward isoproterenol (l0-7 M)-stimulated cAMP production dose-dependently (increase of 10 ± 5% - 79 ± 4% as compared to the propofolattenuated state). Our results suggest that an improvement in cardiac function is provided by olprinone when the β-adrenoreceptor-mediated signaling pathway is inhibited by propofol.
著者キーワード
Propofol
β-adrenoreceptor
Phosphodiesterase-III inhibitor
Olprinone
NDC分類
医学 [ 490 ]
言語
英語
資源タイプ 紀要論文
出版者
Hiroshima University Medical Press
発行日 2008-03
権利情報
(c) Hiroshima University Medical Press.
出版タイプ Version of Record(出版社版。早期公開を含む)
アクセス権 オープンアクセス
収録物識別子
[ISSN] 0018-2052
[NCID] AA00664312